한글목차

세계의 디지털 병리학 시장 규모는 2024년 78억 달러에서 2029년 말 137억 달러에 이를 것으로 예측되며, 2024-2029년 예측 기간 동안 CAGR 11.9%로 성장할 전망입니다.

북미 시장은 2024년에 33억 달러에서 2029년에는 60억 달러로 확대될 것으로 예상되며, 이 기간 CAGR 12.4%로 성장이 전망됩니다. 유럽 시장은 2024년 22억 달러에서 2029년 35억 달러에 이를 것으로 예측되며, 예측 기간 중 CAGR은 10.2%로 성장이 전망됩니다.

본 보고서에서는 세계의 디지털 병리학 시장을 조사했으며, 시장 개요, 시장 영향요인 및 시장 기회 분석, 법규제 환경, 신기술 및 기술 개발 동향, 시장 규모 추이 및 예측, 각종 구분, 지역별 상세 분석, 경쟁 구도, 주요 기업 프로파일 등을 정리했습니다.

목차

제1장 주요 요약

• 시장 전망
• 조사 범위
• 시장 요약

제2장 시장 개요

• 시장 개요
• 디지털 병리학의 역사적 발전
• 기존 프로세스 및 디지털 병리학

제3장 시장 역학

• 개요
• 성장 촉진요인
• 비용 효율의 장점이 디지털 병리학의 확대 촉진
• 검사실의 효율 향상을 목적으로 한 디지털 병리학의 도입 확대
• 암 발생률 증가
• 디지털 병리학에 대한 투자 및 자금 증가
• 억제요인
• 워크플로우 통합의 과제
• 자원이 한정된 국가에서의 도입의 지연
• 기회
• 디지털 병리학의 AI
• 기술의 진보
• 과제
• 병리학 부족 및 불평등한 분포
• 데이터 관리
• 디지털 병리학의 최신 동향
• 보다 우수한 솔루션을 개발하기 위한 공동 연구 및 제휴
• 시장의 성장을 가속하는 혁신
• 클라우드 컴퓨팅에 의한 의료 제공 체제의 강화
• 디지털 및 계산 병리

제4장 규제 상황

• 규제 환경
• 미국
• 유럽

제5장 시장 세분화 분석

• 세분화의 내역
• 개요
• 시장 분석 : 시스템별
• 디지털 IVD 디바이스
• 디지털 병리학 장치
• 디지털 병리학 분석
• 디지털 병리학 커뮤니케이션 플랫폼
• 디지털 병리학 스토리지 플랫폼
• 텔레파솔로지 시스템
• 시장 분석 : 유형별
• 디지털 혈액 및 임상 병리
• 디지털 해부병리
• 디지털 미생물
• 디지털 유전 병리학
• 디지털 면역 병리학
• 디지털 화학 병리학
• 디지털 법의학 병리학
• 시장 분석 : 용도별
• 질병의 진단
• 의약품의 발견 및 개발
• 연구개발 및 기타
• 시장 분석 : 최종 사용자별
• 병원 및 진단센터
• 생명공학 및 제약회사
• 학술센터 등
• 지리적 내역
• 시장 분석 : 지역별
• 북미
• 유럽
• 아시아태평양
• 기타 지역

제6장 새로운 동향 및 기술

• 개요
• 다중화 기법의 진보
• 분자 병리학 진보
• 하이퍼스펙트럼 및 멀티스펙트럼 이미징
• 공간 바이오마커 통합
• 슬라이드 전체의 디지털 이미지
• 클라우드 컴퓨팅 및 디지털 병리학
• 디지털 병리학의 AI
• 디지털 병리학에서 AI의 진보(2024년)

제7장 ESG 동향

• ESG : 서문
• 디지털 병리학 시장에서 ESG의 지속가능성 : 주요 제조업체별
• ESG 위험 평가
• BCC에 의한 견해

제8장 특허 분석

제9장 경쟁 구도

• M&A 및 제휴
• 기업 점유율 분석
• 기타 주요 전략

제10장 부록

• 조사 방법
• 출처
• 약어
• 기업 프로파일
• 3DHISTECH LTD.
• APOLLO ENTERPRISE IMAGING CORP.
• CLINISYS INC.
• CORISTA
• F. HOFFMANN-LA ROCHE LTD.
• FUJIFILM HOLDINGS CORP.
• HURON TECHNOLOGIES INTERNATIONAL INC.
• INDICA LABS LLC.
• KONINKLIJKE PHILIPS NV
• LEICA BIOSYSTEMS NUSSLOCH GMBH
• LIGOLAB INFORMATION SYSTEMS
• MIKROSCAN TECHNOLOGIES INC.
• NIKON INSTRUMENTS INC.
• VISIOPHARM A/S
• XIFIN INC.

영문목차

The global digital pathology market is expected to grow from $7.8 billion in 2024 and is projected to reach $13.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.9% during the forecast period of 2024 to 2029.

The North American digital pathology market is expected to grow from $3.3 billion in 2024 and is projected to reach $6.0 billion by the end of 2029, at a CAGR of 12.4% during the forecast period of 2024 to 2029.

The European digital pathology market is expected to grow from $2.2 billion in 2024 and is projected to reach $3.5 billion by the end of 2029, at a CAGR of 10.2% during the forecast period of 2024 to 2029.

Report Scope

This report analyzes the digital pathology market, providing forecasted trends and sales projections for this market through 2029. It covers key market players, product segments, supporting technologies, emerging trends, competitive intelligence, major geographies and their competitive landscapes, and it offers regional insights. The report's in-depth analysis of market dynamics and their impact(s) forms the foundation for its qualitative assessments and market estimates.

Digital pathology is the process of converting glass slide samples into digital images to enable electronic analysis, storage and sharing. This conversion, which enhances diagnostic accuracy, collaboration and efficiency by facilitating advanced imaging, computational analysis and telepathology, has revolutionized pathology with data-driven insights and remote consultations.

While this report outlines the conventional processes of pathology laboratories, it does not include market analysis for traditional lab devices such as microscopes and slides. The connectivity and network issues discussed are specific to data and information related to pathology lab diagnoses, excluding broader hospital-based mHealth (Mobile Health) concerns. This report's coverage of telepathology is focused on diagnostic applications, research and development (R&D), and education and training but does not address telemedicine at a broader level.

This report addresses regulatory aspects, including innovations; technological advances (patents and approvals); and the latest trends, preferences and developments in digital pathology. As part of its analysis, it segments the digital pathology market by system, type, application and end user. The market has also been segmented into the following major geographies, North America, Asia-Pacific, Europe and the Rest of the World, and there is focused coverage of countries such as the U.S., Canada, Mexico, France, Germany, the U.K., Italy, Spain, Japan, India, Australia, South Korea and China.

Report Includes

• 91 data tables and 57 additional tables
• An analysis of the global market for digital pathology technologies
• Analyses of global market trends, with data from 2021-2023, estimates for 2024, and projections of compound annual growth rates (CAGRs) through 2029
• Descriptions of the upcoming market opportunities for the digital pathology market, factors driving its growth, and forecasts for this market's segments and sub-segments
• Estimates of the market size and forecasts for the digital pathology market in value (USD millions) terms, and a corresponding market share analysis by system, type, application, end user and geographic region
• In-depth information regarding major market dynamics, technology updates, new products and applications, and COVID-19's impact on the market for digital pathology
• Coverage of the technological, economic, and business considerations of the global market for digital pathology, with analyses and market forecasts through 2029
• Information on mergers and acquisitions, agreements, collaborations and product launches in the digital pathology industry
• Analysis of relevant patents
• A discussion of the industry's ESG challenges and practices
• Analysis of the competitive landscape for digital pathology companies, and a value share analysis based on their segmental revenues and financial performance
• Profiles of the leading global companies, including F. Hoffmann-La Roche Ltd., 3DHISTECH Ltd., Nikon Instruments Inc., Danaher Corp., and Indica Labs Inc.

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of Report
• Market Summary

Chapter 2 Market Overview

• Market Overview
• Historical Development of Digital Pathology
• Conventional Process Versus Digital Pathology

Chapter 3 Market Dynamics

• Overview
• Drivers
• Cost-Effectiveness Drives Digital Pathology Expansion
• Growing Adoption of Digital Pathology to Enhance Lab Efficiency
• Increasing Incidence of Cancer
• Increasing Investments and Funding in Digital Pathology
• Restraints
• Workflow Integration
• Slow Implementation of Digital Pathology in Low-Resource Countries
• Opportunities
• AI in Digital Pathology
• Technology Advances
• Challenges
• Shortage and Unequal Distribution of Pathologists
• Data Management
• Current Trends in Digital Pathology
• Collaborations to Develop Better Solutions
• Innovations to Drive Market Growth
• Cloud Computing to Enhance Healthcare Delivery Systems
• Digital and Computational Pathology

Chapter 4 Regulatory Landscape

• Regulatory Environment
• U.S.
• Europe

Chapter 5 Market Segmentation Analysis

• Segmentation Breakdown
• Overview
• Market Analysis by System
• Digital IVD devices
• Digital Pathology Devices
• Digital Pathology Analytics
• Digital Pathology Communication Platform
• Digital Pathology Storage Platform
• Telepathology Systems
• Market Analysis by Type
• Digital Hematology and Clinical Pathology
• Digital Anatomical Pathology
• Digital Microbiology
• Digital Genetic Pathology
• Digital Immunopathology
• Digital Chemical Pathology
• Digital Forensic Pathology
• Market Analysis by Application
• Disease Diagnosis
• Drug Discovery and Development
• R&D and Others
• Market Analysis by End User
• Hospitals and Diagnostic Centers
• Biotech and Pharma Companies
• Academic Centers and Others
• Geographic Breakdown
• Market Analysis by Region
• North America
• Europe
• Asia-Pacific (APAC)
• Rest of the World

Chapter 6 Emerging Trends and Technologies

• Overview
• Advances in Multiplexing Methods
• Advancing Molecular Pathology
• Hyperspectral and Multispectral Imaging
• Spatial Biomarker Integration
• Whole Slide Digital Imaging
• Cloud Computing and Digital Pathology
• AI in Digital Pathology
• Advances in AI in Digital Pathology in 2024

Chapter 7 ESG Developments

• Introduction to ESG
• ESG Sustainability in Digital Pathology Market, by Major Manufacturers
• ESG Risk Ratings
• BCC Research Viewpoint

Chapter 8 Patent Analysis

• Overview
• Digital Pathology

Chapter 9 Competitive Landscape

• Mergers, Acquisitions and Collaborations
• Company Share Analysis
• Other Key Strategies

Chapter 10 Appendix

• Methodology
• Sources
• Abbreviations
• Company Profiles
• 3DHISTECH LTD.
• APOLLO ENTERPRISE IMAGING CORP.
• CLINISYS INC.
• CORISTA
• F. HOFFMANN-LA ROCHE LTD.
• FUJIFILM HOLDINGS CORP.
• HURON TECHNOLOGIES INTERNATIONAL INC.
• INDICA LABS LLC.
• KONINKLIJKE PHILIPS N.V.
• LEICA BIOSYSTEMS NUSSLOCH GMBH
• LIGOLAB INFORMATION SYSTEMS
• MIKROSCAN TECHNOLOGIES INC.
• NIKON INSTRUMENTS INC.
• VISIOPHARM A/S
• XIFIN INC.
• Emerging Start-ups/Market Disrupters